Pancreatic cancer is not only the third leading cause of cancer death in the United States, but also a major public health problem in San Diego. Moores Members Andrew Lowy, MD and Shweta Joshi, PhD are leading groundbreaking research, recently funded by a Lustgarten Foundation Clinical Accelerator Initiative grant, to create new pancreatic cancer treatment therapies. One of these treatments already has been approved by the FDA, which means that its use for treating pancreatic cancer can be expedited. In this Q&A, Dr. Andrew Lowy describes the scope, importance, and reach of his research with Dr. Joshi….Continue Reading Charting New Paths in Pancreatic Cancer Treatment: A Q&A with Lustgarten CAI Grant Recipients

Moores welcomed Thomas F. Gajewski, MD, PhD to present “Expanding Immunotherapy Efficacy by Understanding Mechanisms of Response Versus Resistance,” which was co-hosted by Moores Director, Diane Simeone, MD and Moores Associate Director for Basic Science, J. Silvio Gutkin, PhD, who, along with UC San Diego Health, are eager to understand the mechanisms of checkpoint blockades, their limitations, and the ability to leverage this knowledge to propel advancements in cancer care. …Continue Reading Expanding Immunotherapy Efficacy by Understanding Mechanisms of Response Versus Resistance: Distinguished Scientist Moores Cancer Center Director’s Seminar Series

Moores Member Dr. Anusha Preethi Ganesan is leading groundbreaking research, recently funded by a St. Baldrick’s Grant, to develop needed and effective treatments for Medulloblastoma. In this Q&A, Dr. Preethi Ganesan describes the scope, importance, and influence of her research….Continue Reading Navigating the Frontiers of Medulloblastoma: A Q&A with Anusha Preethi Ganesan, MD, PhD